SFDA Annual Report: Clinical Trial Activity in Saudi Arabia 2025

Summary

The SFDA has published its annual report on clinical trial activity, reporting a 23% increase in CTA submissions and 18% increase in approved trials. Report highlights growth in oncology and metabolic disease trials, increased participation of Saudi national investigators, and improved approval timelines.